Editas Medicine, Inc.
(NASDAQ : EDIT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.34%356.901.2%$818.42m
AMGNAmgen Inc.
-1.00%189.841.2%$543.38m
CELGCelgene Corporation
-0.31%85.081.2%$517.86m
GILDGilead Sciences, Inc.
-0.05%77.010.9%$473.21m
VRTXVertex Pharmaceuticals Incorporated
-1.20%177.961.9%$311.77m
REGNRegeneron Pharmaceuticals, Inc.
-0.33%366.522.6%$283.50m
ILMNIllumina, Inc.
0.44%310.463.5%$265.60m
SRPTSarepta Therapeutics, Inc.
-0.47%134.9016.6%$231.04m
BLUEBluebird Bio, Inc.
1.12%180.9515.7%$204.19m
ALXNAlexion Pharmaceuticals, Inc.
0.01%135.102.0%$176.56m
NKTRNektar Therapeutics
-1.28%48.455.6%$171.83m
EXASExact Sciences Corporation
0.58%68.0025.4%$159.68m
EXELExelixis, Inc.
-0.52%21.236.4%$135.69m
BMRNBioMarin Pharmaceutical Inc.
-0.90%101.944.4%$124.01m
AAgilent Technologies, Inc.
0.15%64.251.5%$122.80m

Company Profile

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu on September 3, 2013 and is headquartered in Cambridge, MA.^ ^ ^